| Alternative Name(s) |
AP26113;1197958-12-5;ALK-IN-1;Brigatinib-analog;UNII-3DGD69C6PV;(2-((5-chloro-2-((4-(4-(dimethylamino)piperidin-1-yl)-2-methoxyphenyl)amino)pyrimidin-4-yl)amino)phenyl)dimethylphosphine oxide;3DGD69C6PV;5-chloro-2-N-[4-[4-(dimethylamino)piperidin-1-yl]-2-methoxyphenyl]-4-N-(2-dimethylphosphorylphenyl)pyrimidine-2,4-diamine;CHEMBL3397300;1197958-12-5 (analog);2,4-Pyrimidinediamine, 5-chloro-N2-[4-[4-(dimethylamino)-1-piperidinyl]-2-methoxyphenyl]-N4-[2-(dimethylphosphinyl)phenyl]-;5-Chloro-N~2~-{4-[4-(dimethylamino)piperidin-1-yl]-2-methoxyphenyl}-N~4~-[2-(dimethylphosphoryl)phenyl]pyrimidine-2,4-diamine;2,4-Pyrimidinediamine, 5-chloro-N2-(4-(4-(dimethylamino)-1-piperidinyl)-2-methoxyphenyl)-N4-(2-(dimethylphosphinyl)phenyl)-;Brigatinib analog;5-Chloro-N2-(4-(4-(dimethylamino)piperidin-1-yl)-2-methoxyphenyl)-N4-(2-(dimethylphosphoryl)phenyl)pyrimidine-2,4-diamine;5-CHLORO-N2-{4-[4-(DIMETHYLAMINO)PIPERIDIN-1-YL]-2-METHOXYPHENYL}-N4-[2-(DIMETHYLPHOSPHORYL)PHENYL]PYRIMIDINE-2,4-DIAMINE;AP26113-analog;Tube723;compound 11q [PMID: 27144831];Brigatinib(AP26113);C26H34ClN6O2P;GTPL7741;SCHEMBL11916416;DTXSID30725416;EX-A770;AP26113;ALK-IN-1;HMS3652H14;HMS3673I09;BCP06648;2218AH;ABP001163;BDBM50062357;MFCD23704187;NSC776763;NSC800977;s7000;ZINC89630357;AKOS025401944;AKOS032949980;AP 26113-analog, Brigatinib-analog;CCG-264698;CS-1368;NSC-776763;NSC-800977;SB16487;NCGC00351602-02;NCGC00351602-05;NCGC00351602-09;5-Chloro-N2-(4-(4-(dimethylamino)-1-piperidinyl)-2-methoxyphenyl)-N4-(2-(dimethylphosphinyl)phenyl)-2,4-pyrimidinediamine;AC-27470;AS-75104;DA-35325;HY-13464;QC-11659;FT-0696829;SW219566-1;A11948;W-6025;Q4653190;5-chloro-2-N-{4-[4-(dimethylamino)piperidin-1-yl]-2-methoxyphenyl}-4-N-[2-(dimethylphosphoryl)phenyl]pyrimidine-2,4-diamine;E5J |
